Daniel Glenn Gibson is CTO at Telesis Bio Inc. (TBIO). They have made 1 open-market trade across 1 company since 2023, most recently 2024-03-01.
CIK 0001866133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBIO | 106,218 | $343K |
Shares reported on the most recent Form 4, priced at the 2024-03-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBIO | SELL | 2023-05-04 | 2023-05-08 | $2.83 | $3K | -28.3% | -51.7% | -55.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.